Abstract: An injectable pharmaceutical composition for veterinary use is disclosed comprising Florfenicol, N-methyl-2-pyrrolidone, polyethylene glycol and a viscosity reducing agent. The composition is chemically and physically stable, exhibits constant blood levels and does not product undesirable side effects.
Type:
Grant
Filed:
August 29, 1990
Date of Patent:
January 21, 1992
Assignee:
Schering Corporation
Inventors:
Henry M. Apelian, David Coffin-Beach, Abu S. Huq
Abstract: 4-Phenyl-1,2,3,4-tetrahydro-1-napthalenamine derivatives have been found useful for the treatment of psychosis, inflammation and as immunosuppressants.
Abstract: Methods useful for inhibiting the release of interleukin-1 and for alleviating interleukin-1 mediated conditions, such as IL-1-mediated inflammation, comprising administration of an effective amount of a pharmaceutically acceptable antioxidant compound such as disulfiram, tetrakis [3-(2,6-di-tert-butyl-4-hydroxyphenyl)propionyloxy methyl]methane or 2,4-di-isobutyl-6-(N,N-dimethylaminomethyl)-phenol.